Publication: 329

Clinical Predictors of Severe Cetuximab-Induced Rash: Observations from 933 Patients Enrolled in North Central Cancer Treatment Group Study N0147
      QxMD      Google Scholar   
Citation:
Oncology vol 77 (2) 120-123
Year:
2009
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
R21CA134432, K24 CA131099, CA-37404, CA-35195, U10 CA037404, U10 CA035195, K24CA131099, CA-25225, R21 CA134432  
Corr. Author:
 
Authors:
           
Networks:
 
Study
NCCTG-N0147
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Cetuximab, Rash, Epidermal growth factor receptor inhibitors, Colon cancer